Valneva SE (VALN:NASDAQ) closed at $5.51 on November 6, 2026, down 2.31% on the day. The stock trades 54.8% below its 52-week high of $12.18 and 16.0% above its 52-week low of $4.75. Over the past year, it lost 38.0%. Valneva SE is part of the Health Care sector.
In 252 trading sessions since November 6, 2025, VALN closed higher on 115 days (46%). Its best day was August 14, 2026 (+26.19%) and its worst was March 23, 2026 (-37.11%). The stock moved 10% or more in a single session 5 times. It opened at least 5% above the previous day's high 8 times.
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes two vaccines for travellers; one for the prevention of Japanese encephalitis (IXIARO) and the second (DUKORAL) for the prevention of cholera and diarrhoea. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, and third-party products; Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; and Technologies and services which relates to services and inventions at a commercialization stage. The group is based in France and operates internationally.
Find more stocks like VALN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.